Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v4-FR
Language English French
Date Updated 2018-09-09 2018-09-08
Drug Identification Number 02243986 02243986
Brand name APO-AMOXI CLAV 125MG/31.25MG PER 5ML APO-AMOXI CLAV 125MG/31.25MG PER 5ML
Common or Proper name AMOXI CLAV AMOXI CLAV
Company Name APOTEX INC APOTEX INC
Ingredients AMOXICILLIN CLAVULANIC ACID AMOXICILLIN CLAVULANIC ACID
Strength(s) 125MG 31.25MG 125MG 31.25MG
Dosage form(s) POWDER FOR SUSPENSION POWDER FOR SUSPENSION
Route of administration ORAL ORAL
Packaging size 100 ml 100 ml
ATC code J01CR J01CR
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2014-10-09 2014-10-09
Estimated end date Unknown Unknown
Actual end date 2018-09-08 2018-09-08
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments